Introduction: Dogs play a primary role in the zoonotic cycle of visceral leishmaniasis (VL). Therefore, the accurate diagnosis of infected dogs, primarily asymptomatic dogs, is crucial to the effi ciency of VL control programs. Methods: We investigated the agreement of four diagnostic tests for canine visceral leishmaniasis (CVL): parasite detection, either after myeloculture or by direct microscopic examination of tissue imprints; kinetoplast-deoxyribonucleic acid-polymerase chain reaction (kDNA-PCR); and an immunochromatographic test (ICT). An enzyme-linked immunosorbent assay (ELISA) and an indirect immunofl uorescence test (IFAT), both of which were adopted as part of the screening-culling program in Brazil, were used as reference tests. Our sample set consisted of 44 seropositive dogs, 25 of which were clinically asymptomatic and 19 were symptomatic for CVL according to ELISA-IFAT. Results: The highest and lowest test co-positivities were observed for ICT (77.3%) and myeloculture (58.1%), respectively. When analyzed together, the overall percentage of co-positive tests was signifi cantly higher for the symptomatic group compared to the asymptomatic group. However, only ICT was signifi cantly different based on the results of a separate analysis per test for each group of dogs. The majority (93.8%) of animals exhibited at least one positive test result, with an average of 2.66 positive tests per dog. Half of the symptomatic dogs tested positive for all four tests administered.
Visceral leishmaniasis (VL) is a chronic parasitic disease caused by the Leishmania donovani complex in East Africa and the Indian subcontinent and by Leishmania infantum (syn. Leishmania chagasi) in Europe, North Africa and Latin America. VL is fatal if left untreated and is transmitted in one of two ways. Zoonotic VL is transmitted from animal to vector to human, and anthroponotic VL is transmitted from human to vector to human. In the former, humans are occasional hosts and dogs are the main reservoir for Leishmania, particularly in rural and urban domestic environments 1 .
Canine visceral leishmaniasis (CVL) is an important public health problem and is a disease of great interest to private veterinary medicine due to its high prevalence in urban areas of Brazil. Infected dogs may present intense cutaneous parasitism 2, 3 and play a primary role in the maintenance of vector infection 4 . Along with measures to control the vector population and early treatment of human cases, euthanasia of infected dogs is part of the VL control policy adopted by the Brazilian Ministry of Health 5 . Early and accurate diagnosis of CVL is of major importance to the effectiveness of control programs. Although several techniques have been proposed to serologically diagnose CVL, a fast and safe diagnostic method with optimal sensitivity and specifi city is not currently available 6 . Until very recently, standard serology in canine surveys of the government VL control program used enzyme-linked immunosorbent assay (ELISA) as a screening method followed by an indirect immunofl uorescence test (IFAT) to confi rm ELISA-positive samples. Currently, this methodology is being replaced by immunochromatographic screening using the Dual Path Platform (DPP CVL, Biomanguinhos, Rio de Janeiro, Brazil) followed by ELISA confi rmation.
METHODS
The main limitation of most diagnostic methods is the detection of asymptomatic but infected dogs. In this context, the present study evaluated the results of four different diagnostic tests for CVL in symptomatic and asymptomatic seropositive dogs from control program surveys in endemic areas of Brazil. Two tests are based on Leishmania visualization, either after culturing or by direct microscopic examination; one test, kinetoplast-deoxyribonucleic acid-polymerase chain reaction, kDNA-PCR, is a molecular biology-based method, and one test is antibody-based but uses a recombinant protein rather than natural Leishmania antigens.
Clinical samples
Forty-four dogs that tested seropositive for CVL according to the standard methodology adopted by the Brazilian Ministry of Health (ELISA and IFAT kits, both produced by the Biomanguinhos Institute, Rio de Janeiro, Brazil) were used in this study. These animals were collected by Zoonosis Control Centers located in three endemic cities for VL in the Brazilian State of Minas Gerais, Montes Claros (16°44'02"S, 43°51'23"W), Janaúba (15º47'50"S, 43º18'31"W) and Paracatu (17°13'01"S, 46°52'17"W), all of which are classified as intense transmission areas for the disease (Brazil 2006). The dogs were examined by veterinary physicians and classifi ed as asymptomatic or symptomatic according to the absence or presence of at least one clinical sign suggestive of canine VL. Serum samples were collected, and bone marrow aspirates were harvested by sterilely puncturing the tibial crest for the preparation of slide smears and parasite cultures. Ear skin, spleen and mesenteric lymph nodes were biopsied, and the tissue fragments were used to prepare slide imprints and to extract total deoxyribonucleic acid (DNA). Euthanasia followed the technical norms defi ned by Resolution no 714 from the Federal Council of Veterinary Medicine (dated 06/02/2002) and by the screening-culling procedure adopted by the Brazilian Ministry of Health in its Program for Visceral Leishmaniasis Control.
Parasite culture
Novy-MacNeal-Nicolle/liver infusion tryptose (NNN/LIT) culture medium was inoculated with bone marrow aspirates and incubated at 25°C. The cultures were examined weekly for the presence of Leishmania promastigotes. After the culture was expanded to approximately 100 million cells, the cells were washed with phosphate-buffered saline (PBS), and positive samples were frozen at -20°C until use. Negative samples were discarded after fi ve weeks of monitoring.
Polymerase chain reaction
Total DNA was organically extracted 7 from Leishmania cultures and biopsied tissues. DNA amplifi cation was performed with A [5'(C/G)(C/G)(G/C)CC(C/A)CTAT(T/A)TTACACCAACCCC3'] and B (5'GGGGAGGGGCGTTCTGCGAA3') primers previously designed to amplify a 120bp segment from the conserved region of the kinetoplast DNA minicircle (kDNA) from the Leishmania genus 8 . The amplifi ed products were visualized by electrophoresis on a 6% polyacrylamide gel after silver staining. The presence of a 120bp band from any of the amplifi ed tissue samples (ear skin, spleen or mesenteric lymph nodes) was considered a positive result. The quality of DNA extraction was verifi ed by amplifying the IV S6 region from a constitutive gene (cacophony) from Lutzomyia 9 .
Immunochromatographic test
Canine sera were tested using the Kalazar Detect™ test (InBios International Inc., Seatle, Washington, USA), which is a rapid immunochromatographic test (ICT) that qualitatively detects antibodies specific for a recombinant Leishmania antigen, rK39, formed by repeats of 39 amino acids. This peptide is a portion of a 230kDa antigen homologous to the kinesin superfamily of motor proteins and encodes a repetitive, highly conserved epitope in L. infantum and L. donovani 10 .
Direct parasitological examination
After Giemsa or panoptic staining, tissue imprints and bone marrow smears were examined for the presence of Leishmania amastigotes using optical microscopy. The observation of parasites in the imprints from any biopsied tissue (ear skin, spleen or mesenteric lymph nodes) was considered a positive test result.
Statistical analysis
The standard serological methodology for canine visceral leishmaniasis (ELISA-IFAT) was used as a reference, and the performance of the tests evaluated in this study was calculated compared to this standard method. Because all of the dogs were positive according to the standard serological method, diagnostic test performance was measured based on precision or accuracy and expressed as the total number of correct classifi cations. In this case, the test precision is equivalent to sensitivity. In addition, given that the reference did not identify certainty of the absence of the disease but instead a serological result, the term sensitivity was replaced with co-positivity (which is equivalent to relative sensitivity).
The co-positivity of the four tests as well as the respective positivity percentages for the two clinical groups of dogssymptomatic and asymptomatic -were compared using the chi-square test 11 . When necessary, Fisher's exact test 11 was employed. The odds ratios and the 95% confi dence intervals were calculated and adjusted for small samples 12 when applicable.
The Mann-Whitney test 13 was employed to compare the number of positive tests among the four tests, in the two clinical groups of dogs (symptomatic and asymptomatic). Agreement between the results of the four tests was verifi ed by calculating the Kappa coeffi cient 14 .
All statistical analyses were performed with R software (version 3.0.1) with a 5% signifi cance level.
Ethical considerations
All of the procedures involving dogs followed the ethical conditions established by the Ethics Committee on Animal Use (CEUA/Fundação Oswaldo Cruz under license no. L013/09), Forty-four dogs seropositive for CVL by ELISA-IFAT were assayed using direct parasitological examination, myeloculture, ICT and kDNA-PCR, and the degree of co-positive tests were evaluated. The highest and lowest co-positivities were obtained for ICT (77.3%) and myeloculture (58.1%), respectively (Table 1) . However, differences in co-positivity were not statistically signifi cant for any of the tests (p-value = 0.237). kDNA-PCR showed variable co-positivity percentages based on the tissue used for DNA extraction: 27.3% for the mesenteric lymph nodes, 36.4% for the spleen and 50% for the skin (data not shown). These differences in percentages were not analyzed because our positivity criterion was the presence of a positive result in any of the three tissues tested. The DNA extracted from the Leishmania biomass served as an internal control for the extraction process, with positive results in 100% of the samples (data not shown).
RESULTS

DISCUSSION
Of the 44 dogs in our sample, 25 were clinically symptomatic and 19 were asymptomatic. Table 2 depicts the test results for each clinical condition. Although we observed a tendency towards a higher percentage of co-positivity in the symptomatic group compared to the asymptomatic group, the differences for each test were not signifi cantly different except for ICT. This particular assay exhibited 100% co-positivity for symptomatic dogs compared to 60% in asymptomatic dogs, a statistically signifi cant difference (Figure 1) . According to the odds ratio, the chance of a positive ICT result in the asymptomatic group was 11.88 [1.43; 487.0] times greater than in the symptomatic group.
The majority (93.8%) of dogs exhibited at least one positive CVL result for the diagnostic tests used in this study, with an average of 2.66 positive test results per dog (Table 3) . When the clinical group of dogs was analyzed separately, the average number of positive tests decreased to 2.28 in the asymptomatic group and increased to 3.16 in the symptomatic group (Table 3) . Further analysis calculating the median value per clinical group indicated that at least 50% of the asymptomatic animals tested positive for two of the diagnostic tests for CVL. In the symptomatic group, half of the animals showed positive results for all four tests. Comparing the canine clinical groups, the total number of positive tests was significantly different (p-value = 0.041) (Figure 2) . Three of the asymptomatic dogs were not co-positive for any of the diagnostic tests (data not shown).
According to the calculated κ value, there was little agreement between the results from the four diagnostic tests for CVL (κ = 0.348). However, the corresponding p-value (p-value = 0.000) indicates that the tests exhibited signifi cant agreement.
In Brazil, despite efforts from the Ministry of Health to control CVL vectors and reservoirs, VL is undergoing rapid territorial expansion 15 . The recent adoption of DPP CVL as the screening step for canine surveys is advantageous because the delay between diagnosis and culling/treatment is decreased. Currently, the long duration between sample collection and culling, as well as the complexity of performing the procedure, have been suggested as reasons for its low effi cacy 4, 16, 17 .
When diagnosing human patients with the goal of detecting the clinical disease, other rapid tests have proven to be sensitive and specifi c [18] [19] [20] [21] . However, when the goal is detecting canine infection for control purposes, these tests demonstrated low sensitivity and were useful only for the confi rmation of infection in suspicious clinical cases [22] [23] [24] [25] [26] [27] . Therefore, it follows that ICT identifi ed 100% of the symptomatic dogs in our hands but only identifi ed 60% in the asymptomatic group.
PCR is considered highly sensitive and specifi c, can be automated, and is applicable to different types of biological samples [28] [29] [30] [31] [32] [33] . As previously noted 4 , in contrast to antibodybased assays, antigen-based methods such as PCR might become more relevant indicators of infection in the future, as these tests can still be used in vaccinated dogs that will test as antibody-positive. In our hands, kDNA PCR identifi ed only 64% of the samples as positive. Two reasons could justify this unexpectedly low percentage: the methodology we employed for DNA extraction and/or a limitation of the technique itself. In the fi rst case, residue of PCR inhibitors from the organic DNA extraction could lead to false negative results. However, this is unlikely because the internal control (DNA extracted from the Leishmania biomass) was assayed with the same methodology and tested 100% positive. Concerning the technique itself 34 , a previous study reported a decrease in PCR sensitivity over the course of CVL infection, from 78-88% at the 135th day post-infection to approximately 50% after 300 days. Thus, the sensitivity of PCR for CVL diagnosis might depend on the sampling time during infection. For our samples, this time point is unknown.
The tendency towards higher co-positivity percentages in symptomatic dogs compared with asymptomatic dogs, which was consistently observed in this study, agrees with the literature for several diagnostic tests 2, 3, [34] [35] [36] [37] [38] [39] . Depending on the assay, this may be related to higher antibody titers or to higher parasite loads in clinically ill dogs 2 . However, a statistically signifi cant difference in test co-positivities between the two clinical groups of dogs was only observed for ICT. Unfortunately, a fi nal conclusion determining the agreement of the results from the four tests employed in this study was not possible. The κ value and the p-value suggest different conclusions, possibly due to our sample size, which precluded a more thorough analysis. Despite testing positive serologically, three dogs from the asymptomatic group, including a three-to-four-month-old puppy, tested negatively for all of the administered tests. Possible explanations include false seropositivity 40 , cross-reactivity with other diseases 41 or the presence of a pre-patent infection 42, 43 . In the case of the puppy, the positive serology might also be attributable to the presence of maternal antibodies 44 .
Published estimates for antibody-based immunofl uorescence assays range from 72 to 100% sensitivity and 52 to 100% specifi city 4 . One reason for the limited specifi city of antibodybased tests is that they are generally manufactured with antigens from Leishmania major [45] [46] [47] instead of Leishmania infantum because the latter is diffi cult to culture and mass produce in artifi cial media 47, 48 . Differences between these Leishmania species likely compromise the fi nal test results. In our hands, even parasitological diagnosis, which is considered the gold standard for CVL diagnosis, did not reach 100% co-positivity, even in the symptomatic group.
Ideally, a test for CVL diagnosis should detect asymptomatic infection, have high sensitivity, specifi city and reproducibility, and be simple, easy to perform, inexpensive, and viable to use in regional laboratories or adaptable to fi eld conditions. This test should detect all dogs infected with Leishmania, and use samples that can be collected non-invasively 43 . Despite the technological advances made in the development of CVL diagnostic tests, the primary limitation for most tests is the diagnosis of asymptomatic dogs. A previous study 16 suggests that the effectiveness of control programs could be higher if euthanasia was directed towards infective dogs not infected, dogs, which would require a specifi c test to predict infectivity. Unfortunately, the development of such a test is a hurdle to improving the success of CVL control programs. This study reinforces the idea that more sensitive and specifi c tests need to be developed before the effi cient diagnosis of canine VL can be realized.
